Company profile for Aplagon

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Aplagon is a clinical-stage biopharmaceutical company developing first-in-class therapies for thromboinflammatory diseases. Built on pioneering research by Prof. Riitta Lassila’s group at Wihuri Research Institute in Finland, Aplagon’s lead candidate, APAC, is a heparin proteoglycan mimetic. With a strong scientific foundation, APAC is now advancing through clinical studies for two cardiovascular indications, aiming to pro...
Aplagon is a clinical-stage biopharmaceutical company developing first-in-class therapies for thromboinflammatory diseases. Built on pioneering research by Prof. Riitta Lassila’s group at Wihuri Research Institute in Finland, Aplagon’s lead candidate, APAC, is a heparin proteoglycan mimetic. With a strong scientific foundation, APAC is now advancing through clinical studies for two cardiovascular indications, aiming to provide innovative solutions for patients with unmet medical needs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Finland
Address
Address
Biomedicum Helsinki 2A Tukholmankatu 8 A, 00290 Helsinki
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com//news-release/2025/02/03/3019222/0/en/Aplagon-Announces-EUR-7-Million-Financing-to-Advance-its-APAC-Therapeutic-for-Thrombo-Inflammatory-Diseases-into-Phase-2A-Clinical-Trials.html

GLOBENEWSWIRE
03 Feb 2025

https://pharmatimes.com/news/aplagon-secures-eur-7-million-for-apac-phase-2a-trials/

PHARMATIMES
03 Feb 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty